Outsourcing is an important means for clinical trial sponsors to bring in outside...
- How to Enable Greater Budget Forecasting
- Poor Communication Can Cost You – REALLY Cost You
- Execution: A Key Success Factor in All Sponsor-CRO Collaborations
- Patient Recruitment and Retention Considerations for Clinical Trials in Latin America
- Expert Insights: Fifteen Percent of 503B Compounding Outsourcing Facilities Have Violated FDA Regulations
Alexander O’Leary Q&A: how are clinical trial sponsors’ outsourcing activities evolving?
Outsourcing is an important means for clinical trial sponsors to bring in outside expertise, from full-service clinical research organisations to smaller functional service providers. Here, Arena International portfolio director Alexander O'Leary discusses the latest trends in clinical trial outsourcing, as well as the impact of the ongoing Covid-19 pandemic.
MDMA Treatments Found to Eliminate PTSD Symptoms in Phase II Trial
Gavin Davidson, CVMD Analyst, GlobalData, examines how MDMA is used to treat patients with PTSD
To Outsource or Not to Outsource? That is the Question
Lisa Henry, Manager of Clinical Research, Cordis, discusses the merits of clinical trial outsourcing models
Execution: A Key Success Factor in All Sponsor-CRO Collaborations
Ken Getz, Tufts CSDD, examines why the sponsor-CRO dynamic often falls short of expectations
Announcing ‘The Return of Outsourcing Week’ on Clinical Trials Arena
Throughout this week, CTA will spotlight the ever-changing outsourcing landscape
Patient Recruitment and Retention Considerations for Clinical Trials in Latin America
Wagner Souza, Clinical Research Manager, AstraZeneca Brazil, shares his thoughts about the challenges of patient recruitment and retention in Latin America